Arthur A. Boni, PhD

Arthur A. Boni, Ph. D. is a serial entrepreneur with a career spanning the private sector and academia in multiple locations in the US including San Diego, Silicon Valley, Boston, and Pittsburgh. He has focused his entrepreneurial efforts on both technology and biopharma. After receiving a Ph.D. in Engineering Science/Engineering Physics from UC San Diego, Boni started an academic tenure-stream appointment in Engineering and Applied Science at Yale and then took an entrepreneurial leave. As a Sr. VP, he built and managed a business unit for Science Applications International Corporation in LaJolla, CA as it grew into the billion-dollar (“unicorn”) level. He then began to focus on startups, thru two technology companies in the Boston area where he led early versions of an accelerator to nurture early-stage companies in technology, biopharma, and health care. After a successful 25-year career in the private sector, he moved to Pittsburgh in 1996, and “reentered academia” as the founder of the Office of Technology Management at the University of Pittsburgh, and its School of Medicine. He launched the Office of Technology management and implemented systems for the development and management of IP and the launch of startup companies. After a 5-year startup and growth stage, he moved to Carnegie Mellon University where he led the Donald H. Jones Center for Entrepreneurship based in the Tepper School of Business but serving the entire campus. The program was recognized as top-10 internationally. During that stage, he was a very active participant in the development of the Pittsburgh emerging ecosystem based on life science and technology companies based on science and technology originating from both universities. While at CMU he also co-founded the Entrepreneurship Boot Camp in 2005, in partnership with BIO.

In 2018, Dr. Boni took Emeritus status, moved to Napa, CA, and is currently the John R. Thorne Distinguished Career Professor of Entrepreneurship, Emeritus at the Tepper School of Business. He is currently Editor in Chief at the Journal of Commercial Biotechnology, a premier, peer-reviewed international journal that provides content relevant to building the “business side” of the life sciences industry that includes biopharma, MedTech, and digital health. He has launched a strategy to provide relevant content focused on contributed articles, while in parallel, developing Special Editions based on solicited articles on topics of interest to the industry. These include: “Commercialization and Innovation”; “Entrepreneurship Boot Camp 2.0”; “Emerging Transformative Technologies, Promises, and Challenges”; “Ecosystems and Clusters in the US and globally”; and, “Recognizing and Celebrating Innovation and Innovators in Life Sciences” (an annual issue). The latest edition is developed in partnership with the UC San Diego (schools of engineering, business, and digital health). This is focused on “Clinical and Commercial Opportunities in Digital Health.”